Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
0,05%0,11%33.87x6.29x8.75x26.57x27.32x 56,65 Md
1,68%1,95%17.88x3.41x5.37x11.67x13.62x 47,49 Md
-.--%-.--%-17.89x1.1x4.19x-7.32x-6.01x 22,81 Md
-.--%-.--%-37.29x50.09x12.29x-35.84x-38.57x 21,37 Md
-.--%-.--%20.03x1.97x3.88x10.08x12.13x 16,12 Md
-.--%-.--%21.92x2.49x4.38x14.5x16.15x 15,56 Md
-.--%-.--%16.24x4.6x4.67x10.96x12.01x 12,91 Md
-.--%0,13%42.57x10.56x16.5x48.46x43.17x 12,86 Md
-.--%-.--%-409.68x16.81x27.83x-3103.12x-304.64x 11,67 Md
-.--%-.--%-74.66x26.31x7.55x-67.73x-55.09x 11,82 Md
-.--%-.--%-25.97x26.67x23.79x-30.55x-24.72x 11,55 Md
-.--%-.--%-12.25x-50.75x93.03x-13.88x-13.51x 10,75 Md
-.--%-.--%-12.71x149.62x3308.99x-15.39x-12.56x 11,08 Md
-.--%0,02%1867.71x6.86x11.89x73.49x241.35x 9,75 Md
-.--%-.--%-21.52x8.25x798.08x-18.7x-18.61x 9,75 Md
-.--%-.--%9.85x4.72x6.95x11.26x11.89x 7,73 Md
-.--%-.--%-32.64x8.97x - -29.81x-28.84x 8,71 Md
-.--%-.--%-6.12x - - -6.27x-5.77x 7,52 Md
Moyenne 0,1% 0,12% 76,63x 16,35x 271,14x -173,42x -7,26x 17,01 Md
Moyenne pondérée par Capi. 0,27% 0,33% 47,32x 13,63x 165,00x -114,66x -1,37x
Médicaments bio-thérapeutiques
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT